Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...
“A large market has emerged for the use of microarrays in novel applications, such as CGH, ChIP-chip, and DNA methylation,“ Nuwaysir adds. “Traditional gene-expression microarray experiments offer a ...
Protein multiplex sandwich immunoassay: A reliable and objective method for complete molecular characterization of breast cancer from core needle biopsies ...
Multicenter Phase II Trial of Immunotherapy With the Humanized Anti-CD22 Antibody, Epratuzumab, in Combination With Rituximab, in Refractory or Recurrent Non-Hodgkin's Lymphoma Genomic losses were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results